Evaluation of the von Willebrand factor Y1584C polymorphism as a potential risk factor for bleeding in patients receiving anticoagulant treatment with vitamin K antagonists

P Tjernberg, JF Van Der Heijden, JCJ Eikenboom, PH Reitsma*

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)797-798
Number of pages2
JournalJournal of Thrombosis and Haemostasis
Volume3
Issue number4
Publication statusPublished - Apr 2005

Keywords

  • THROMBOMODULIN
  • COMPLICATIONS

Cite this